Allergen Plc, Novartis AG, Santen Pharmaceuticals Co, Ltd., Akorn, and Pfizer)
LONDON, Oct. 20, 2020 (GLOBE NEWSWIRE) -- This has shifted resources from the antiglaucoma drugs market to the antiviral drug therapies market. The coronavirus outbreak has also caused shortage in...





